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Congocidine (netropsin) is a pyrrole-amide (oligopyr-
role, oligopeptide) antibiotic produced by Strepto-
myces ambofaciens. We have identified, in the right
terminal region of the S. ambofaciens chromosome,
the gene cluster that directs congocidine biosyn-
thesis. Heterologous expression of the cluster and
in-frame deletions of 8 of the 22 genes confirm the
involvement of this cluster in congocidine biosyn-
thesis. Nine genes can be assigned specific functions
in regulation, resistance, or congocidine assembly. In
contrast, the biosynthetic origin of the precursors
cannot be easily inferred from in silico analyses. Con-
gocidine is assembled by a nonribosomal peptide
synthetase (NRPS) constituted of a free-standing
module and several single-domain proteins encoded
by four genes. The iterative use of its unique adenyla-
tion domain, the utilization of guanidinoacetyl-CoA
as a substrate by a condensation domain, and the
control of 4-aminopyrrole-2-carboxylate polymeriza-
tion constitute the most original features of this NRPS.
INTRODUCTION
Pyrrole-amides, sometimes also called oligopyrroles or oligo-
peptides, are a family of natural products containing one or
several pyrrole-2-carboxamides. They are synthesized by
Streptomyces and related actinobacteria and have a variety of
biological activities including antiviral, antibiotic, antitumor, and
antihelmintic activities. The two best-known members of the
pyrrole-amide family are congocidine (also called netropsin)
and distamycin (Figure 1). Isolated about 50 years ago, they
have been extensively studied due to their ability to bind to the
minor groove of the DNA double helix in a sequence-specific
manner and have served as models for the study of DNA
minor-groove binders. In particular, it has been shown thatChemistry & Biology 16they bind DNA reversibly through hydrogen bonds, van der
Waals contacts, and electrostatic interactions at sequences of
four or more consecutive A-T pairs and strongly discriminate
against G-C pairs (Neidle, 2001).
Molecules capable of binding specific DNA sequences, such
as congocidine and distamycin, are attracting considerable
interest because they could potentially be used to regulate the
expression of particular genes involved in various diseases
such as cancer. Consequently, many analogs and hybrids of
congocidine and distamycin have been synthesized chemically
in attempts to modify or increase the sequence specificity of
the DNA binding, or to create molecules capable of binding to
DNA covalently and possessing potential antitumor activities
(Neidle, 2001). Congocidine and distamycin are not among the
most efficient minor-groove DNA-binder anticancer agents, as
they do not bind DNA covalently. However, it has been sug-
gested that a recently discovered member of the pyrrole-amide
family, pyrronamycin B, binds DNA in a covalent manner and
exhibits antitumor activities (Asai et al., 2000). Moreover, congo-
cidine and distamycin have been used as sequence-selective
carriers of alkylating agents. Thus, for example, tallimustine, a
benzoic acid mustard derivative of distamycin, has been in
phase I and II clinical trials as an anticancer agent (Denny,
2001). Congocidine and distamycin analogs have also been
coupled with known antitumor agents (or their active moiety)
such as anthramycin (specific for GC-rich regions); the resulting
hybrid molecules display antitumor activity (Baraldi et al., 2003).
Although the nature of the interactions of distamycin and con-
gocidine with the minor groove of DNA has been extensively
studied, little is known about the biosynthesis of these molecules:
incorporation experiments with isotopically labeled precursors
have shown that the guanidinium moiety of congocidine origi-
nates from arginine (Wildfeuer, 1964), and genes that confer
resistance to congocidine (netropsin) have been characterized
in Streptomyces flavopersicus NRRL 2820 (synonym: Strepto-
myces netropsis) (Stumpp et al., 2005). However, no gene cluster
directing the biosynthesis of a pyrrole-amide has been isolated.
Streptomyces ambofaciens, the industrial producer of spiramy-
cin, has been known since 1952 to produce congocidine, 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 421
Chemistry & Biology
Congocidine Biosynthetic Gene Cluster(Cosar et al., 1952). Recently, the extremities of the linear chro-
mosome of this bacterium have been sequenced (Choulet
et al., 2006). As gene clusters involved in secondary metabolites
are mostly found in the arms of the Streptomyces chromosome,
we wondered whether the gene cluster directing the biosynthesis
of congocidine in S. ambofaciens was located in the sequenced
extremities. We report here the identification, delimitation, and
analysis of the congocidine biosynthetic gene cluster from
S. ambofaciens. We show that congocidine is assembled by an
atypical nonribosomal peptide synthetase (NRPS), constituted
of a free-standing module and several single-domain proteins.
This enzyme contains a unique adenylation domain that acts iter-
atively and a condensation domain that uses CoA-activated
rather than peptidyl carrier protein (PCP)-phosphopantetheinyl
(Ppant)-activated guanidinoacetate as a substrate. To our knowl-
edge, this work constitutes the first characterization of a pyrrole-
amide biosynthetic gene cluster and should facilitate the isolation
and study of biosynthetic pathways of other known or new
pyrrole-amides.
RESULTS AND DISCUSSION
In Silico Identification of a Candidate Congocidine
Biosynthetic Gene Cluster in the S. ambofaciens
Chromosome
About 1.3 Mb of each of the extremities of the S. ambofaciens
ATCC23877 chromosome has been sequenced (Choulet et al.,
2006). Sequence analysis of these regions reveals the presence
of at least nine putative secondary metabolite gene clusters,
including gene clusters directing the biosynthesis of alpomycin
(Pang et al., 2004) and coelichelin (Barona-Go´mez et al., 2006).
One of these putative secondary metabolite gene clusters,
located in the right arm of the chromosome, was identified by
a clear break of synteny in a region otherwise syntenic with the
chromosome of Streptomyces coelicolor, a species that does
not synthesize congocidine. Between the regions of synteny,
24 genes (SAMR0898 to SAMR0921), encoding products with
A 
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Figure 1. Chemical Structures of Congocidine and Distamycin
(A) Congocidine.
(B) Distamycin.
The dashed lines separate the putative precursors.422 Chemistry & Biology 16, 421–431, April 24, 2009 ª2009 Elsevieno or low similarity to S. coelicolor proteins, occupy a region of
about 31 kb. Four of these genes code for nonribosomal peptide
synthetases, enzymes typically involved in secondary metabo-
lism; two other genes, SAMR0920 and SAMR0919, code for
proteins homologous to NetP1 and NetP2 from S. flavopersicus
(Stumpp et al., 2005). NetP1 and NetP2 confer resistance to
netropsin (congocidine) on this bacterium. These various obser-
vations suggested that the gene cluster identified may direct the
biosynthesis of congocidine.
Involvement of the SAMR0898–09021 Gene Cluster
in Congocidine Biosynthesis
To verify the involvement of the SAMR0898–0921 gene cluster in
congocidine biosynthesis, we inactivated SAMR0901 (encoding
an NRPS enzyme). SAMR0901 was disrupted by homologous
recombination between the S. ambofaciens SPM110 chromo-
some and a suicide plasmid (pJMC101; see Table S1 available
online) containing an internal fragment of SAMR0901. The anti-
bacterial activity of the mutant strain, CGCA004, was then
tested. Patches of S. ambofaciens SPM110 (in which production
of spiramycin is abolished) and CGCA004 were grown on HT,
a medium on which this species produces congocidine. After
4 days, plates were overlaid with soft nutrient agar containing
the indicator microorganisms Escherichia coli or Bacillus subtilis.
Growth inhibition was observed around SPM110, but not around
CGCA004, suggesting that production of congocidine was abol-
ished (data not shown). Both SPM110 and CGCA004 were also
grown for 4 days in liquid MP5 medium, and culture supernatants
were analyzed by HPLC. A peak around 14.9 min observed in the
chromatogram of SPM110 culture supernatant was absent from
the chromatogram of CGCA004 (Figures 2A and 2B). Compar-
ison with authentic standard and LC-MS-MS analysis confirmed
that this peak corresponds to congocidine (data not shown).
Thus, SAMR0901 inactivation abolishes congocidine production
and confirms the involvement of this gene in congocidine biosyn-
thesis. As genes directing the biosynthesis of a given secondary
metabolite are usually clustered, we hypothesized that the
24 nearby genes (SAMR0898–0921) constituted the congocidine
biosynthetic gene cluster.
Heterologous Expression of the SAMR0898–0921
Gene Cluster
To determine whether the SAMR0898–0921 gene cluster is suffi-
cient to direct congocidine biosynthesis in Streptomyces, we
introduced the entire gene cluster into heterologous hosts.
For sequencing purposes, a library of S. ambofaciens
ATCC23877 genomic DNA has been constructed in pBelo-
BAC11 (Choulet et al., 2006) and the ends of the inserts of about
5000 bacterial artificial chromosomes (BACs) from this library
have been sequenced. Using these sequences, we identified
one BAC, the insert of which contains all 24 genes of the putative
cluster. The insert of this BAC, which we named pCGC001,
includes the 43 kb region of the S. ambofaciens chromosome
located between SAMR0888 and SAMR0926.
For conjugational transfer of pCGC001 and its integration into
the Streptomyces chromosome, a DNA fragment containing the
hygromycin resistance gene, the FC31 integrase gene, the cor-
responding attP sequence, and oriT (the transfer origin of the
RK2 plasmid) was inserted into this BAC. The resulting BACr Ltd All rights reserved
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Figure 2. HPLC Analyses of Congocidine Production
(A) SPM110 (S. ambofaciens strain producing congocidine).
(B) CGCA004 (S. ambofaciens mutant strain with disruption of SAMR0901).
(C) CGCL006 (S. lividans TK23 harboring pCGC002 with the complete congo-
cidine cluster).
(D) CGCL017 (S. lividans TK23 harboring pCGC213 [in-frame deletion of cgc10
in the congocidine cluster]).
(E) CGCL031 (S. lividans TK23 harboring pCGC223 [in-frame deletion of cgc15
in the congocidine cluster]).
Absorbance was monitored at 297 nm.Chemistry & Biology 16was named pCGC002 and introduced into the heterologous host
Streptomyces lividans TK23, yielding the strain CGCL006. This
strain shows antibacterial activity against E. coli and B. subtilis
whereas the parental S. lividans TK23 does not, which suggests
that it produces congocidine. This was confirmed by HPLC
(Figure 2C) and LC-MS analyses of culture supernatants.
Furthermore, CGCL006 produces a quantity of congocidine
comparable to that produced by S. ambofaciens SPM110.
Thus, it constitutes a convenient tool for studying the congoci-
dine biosynthetic gene cluster.
Three other heterologous hosts (S. coelicolor M145, Strepto-
myces fungicidicus B-5477, and Streptomyces albus) were
also tested. In all cases, integration of pCGC002 into their chro-
mosome led to the production of congocidine, a molecule that
they do not naturally produce (Figure S1). This suggests that
the SAMR0888–0926 region of the S. ambofaciens chromosome
might be sufficient for congocidine production in Streptomyces.
Identification of the Limits of the Congocidine
Gene Cluster
To determine the ends of the congocidine biosynthetic gene
cluster, genes upstream from SAMR0898 and downstream
from SAMR0921 were deleted in two steps from the insert of
pCGC002 (Figure S2). First, the DNA between SAMR0898 and
pBeloBAC11was replaced with the excisable apramycin cassette
att3aac (similar to cassettes described by Raynal et al., 2006)
by PCR targeting. The resulting BAC was named pCGC016. The
att3aac cassette was then excised using the plasmid pOSInt3
to give a BAC named pCGC017 (Table S1). The same procedure
was applied to delete the DNA between SAMR0921 and
pBeloBAC11 from pCGC017, yielding pCGC018 (containing the
apramycin cassette) and subsequently pCGC019 (cassette
excised) (Table S1). Thus, pCGC019 contains only the 24 genes
of the putative cluster. The BAC pCGC019 was introduced into
S. lividans TK23 by conjugation. The resulting mutant strain
was named CGCL010. HPLC analysis detected congocidine in
CGCL010 culture supernatants, suggesting that the 24 genes
SAMR0898–0921 are sufficient for congocidine production in
Streptomyces (Figure S3A).
Genes located at each extremity of the putative cluster were
deleted to map its ends more precisely. SAMR0921 was deleted
in-frame from pCGC002 using the PCR targeting technology. The
resulting BAC, pCGC221, was introduced intoS. lividans TK23 to
give CGCL030. HPLC analysis of CGCL030 culture supernatant
showed that congocidine production is abolished by the deletion
of SAMR0921 (Figure S3B). Therefore, this gene is essential for
congocidine production and defines one of the extremities of
the congocidine gene cluster.
SAMR0898 was similarly deleted in-frame from the other end of
the cluster in pCGC019, yielding pCGC029. This BAC was intro-
duced into S. lividans TK23 to give CGCL026. Congocidine was
detected in CGCL026 culture supernatant (Figure S3C), indi-
cating that this gene is not essential for congocidine production.
SAMR0899 was then deleted in-frame from pCGC019, and the
resulting BAC, pCGC030, was introduced into S. lividans TK23
to give CGCL027. CGCL027 culture supernatant contained con-
gocidine, showing that SAMR0899 is not required for congocidine
biosynthesis (Figure S3D). However, deletion of SAMR0900 using
the same procedure yieldedS. lividansTK23 strain CGCL028 that, 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 423
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therefore essential for congocidine biosynthesis and delimits
the other extremity of the congocidine gene cluster.
Overview of the Congocidine Biosynthetic Gene Cluster
We named the 22 genes constituting the congocidine biosyn-
thetic gene cluster cgc1* to cgc3* (SAMR0919 to SAMR0921)
and cgc1 to cgc19 (SAMR0918 to SAMR0900) (Figure 3). Table 1
presents an overview of the predicted function of each of the cgc
gene products, and a possible role for these products in congo-
cidine biosynthesis. Of these 22cgcgenes, two (cgc1* andcgc2*)
are predicted to confer resistance to congocidine and one (cgc1)
probably codes for a regulator of congocidine biosynthesis. The
remaining 19 genes code for putative enzymes, with the possible
exception of cgc7: the product of this gene does not share signif-
icant similarities with any known or hypothetical proteins present
in databases. Eight of the 19 genes (cgc3*, cgc2, cgc7, cgc10,
cgc15, cgc16, cgc18, and cgc19) were each individually deleted
in-frame in the BAC pCGC002 containing the complete cluster.
None of the S. lividans TK23 strains harboring the deleted BACs
produced congocidine (Figures 2D and 2E; Figures S3B and
S3E; data not shown). In some cases (e.g., Figure S3E), new
peaks were observed in the HPLC analyses of the culture super-
natants of these strains. It is not known at the moment whether
they correspond to biosynthetic intermediates or to shunt metab-
olites (except for the cgc15 deletion mutant; see below). We
propose that the 19 cgc genes not involved in congocidine resis-
tance or regulation of biosynthesis direct either the biosynthesis
of congocidine precursors (13 genes) or the assembly of the
molecule (6 genes) (Figure 3).
Assembly of the Congocidine Molecule
A retrobiosynthetic analysis suggests that congocidine is assem-
bled from three precursors: guanidinoacetate, 3-aminopropiona-
midine, and 4-aminopyrrole-2-carboxylate or 4-amino-1-methyl-
pyrrole-2-carboxylate, depending on the timing of N-methylation
of the pyrrole groups (Figure 1A). Moreover, amide bond forma-
tion between these putative precursors may be catalyzed by an
NRPS, as previously suggested (Stumpp et al., 2005). NRPSs
are large modular multienzymatic complexes responsible for
the biosynthesis of most nonribosomal peptides. In canonical
NRPSs, each module catalyzes the incorporation of one amino
acid and consists of domains responsible for a particular stage
Figure 3. Genetic Organization of the Con-
gocidine (cgc) Gene Cluster
of the reaction: adenylation (A) domains
activate and transfer amino acids to
the phosphopantetheinyl arm of peptidyl
carrier protein (PCP) domains; condensa-
tion (C) domains catalyze the elongation of
the peptidyl chain; and the hydrolysis of
the chain from the enzyme is generally
catalyzed by a thioesterase (Te) domain
located at the end of the last module.
Sequence analysis indicates the pres-
ence of four NRPS genes (cgc2, cgc16,
cgc18, and cgc19) in the cgc cluster, and in-frame deletions of
these genes confirmed their involvement in congocidine biosyn-
thesis (Figure S3E; data not shown). The four NRPS genes,
however, code for discrete modules or domains, not for large
multimodular enzymes as usually observed. Thus, cgc18
encodes a typical NRPS module containing an A domain, a
PCP domain, and a C domain. In addition to cgc18, two genes—
cgc2 and cgc16—encode two stand-alone C domains and one
gene—cgc19—a stand-alone PCP domain.
The assembly of congocidine from its putative precursors
requires the formation of three amide bonds. This necessitates
the activation of the carboxylate groups of two 4-aminopyrrole-
2-carboxylate molecules and one guanidinoacetate molecule.
However, other than the A domain of Cgc18 (Cgc18_A), only one
enzyme encoded within the cgc gene cluster is likely to catalyze
the activation of one of these groups. This enzyme, Cgc3*, belongs
to the AMP-binding superfamily of proteins and resembles acyl-
CoA synthetases. One of Cgc18_A and Cgc3* probably acts itera-
tively to activate the two pyrrole precursors, the other enzyme
activating guanidinoacetate. The amino acids identified by estab-
lishedmodels (Challisetal., 2000; Stachelhaus etal., 1999) as likely
to confer substrate specificity in Cgc18_A (S235V236E239Q278V299
G301E322V330S331K517, GrsA-PheA numbering) do not allow the
probable substrate for this domain to be predicted by comparison
with databases (NRPSpredictor; Rausch et al., 2005). In particular,
they differ from the amino acids (D235F236H239F278I299T301H322
D330A331K517) conferring specificity on the CyrB_A domain, which
has been proposed to activate guanidinoacetate in cylindrosper-
mopsin biosynthesis (Mihali et al., 2008). No A domain is known
to activate pyrrole substrates. Indeed, it has been suggested
that activation of pyrrole-2-carboxylate may be hampered by the
weak acidity of the carboxylate (Walsh et al., 2006). It is therefore
possible that the molecule activated is not 4-aminopyrrole-2-
carboxylate, but a precursor of this molecule (see discussion con-
cerning pyrrole biosynthesis below). From this analysis, it appears
to be difficult to predict the substrate of either Cgc3* or Cgc18_A.
Nonetheless, if the two PCP domains are functional, they are likely
to be loaded by the sole adenylation domain encoded in the cgc
cluster, Cgc18_A. In this hypothesis, the same molecule is loaded
onto the two PCP domains. As there are two pyrrole moieties but
one guanidinoacetate moiety in congocidine, we propose that
Cgc18_A activates two molecules of 4-aminopyrrole-2-carbox-
ylate (or its precursor) and transfer the activated groups to the424 Chemistry & Biology 16, 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved
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is therefore likely to be activated by Cgc3*, under the form of gua-
nidinoacetyl-CoA.
In this model, Cgc18_A is proposed to act iteratively to load
Cgc18_PCP in cis and Cgc19 in trans. Iterative use and trans-
adenylation activity of A domains have already been reported
(for a review, see Haynes and Challis, 2007). In yersiniabactin
biosynthesis, for instance, a single adenylation domain loads
three PCP domains (one incis, two in trans) (Keating et al., 2000a).
Based on the above analysis and on gene deletion studies, we
propose the following model for congocidine assembly (Figure 4):
the activated pyrrole precursors are transferred to Cgc18_PCP
and Cgc19, and condensation of these two molecules is then
catalyzedbythecondensationdomainofCgc18 togiveabipyrrole
molecule covalently attached to Cgc19. The two free-standing
condensation domains—Cgc2 and Cgc16—catalyze then the
sequential addition of the activated guanidinoacetyl-CoA and
3-aminopropionamidine, yielding a demethylated form of congo-
cidine. It is unclear which enzyme is responsible for the addition of
which precursor. N-methylation of the pyrrole groups by the SAM-
dependent methyltransferase Cgc15 is then the final step of con-
gocidine biosynthesis.
Order of the Condensation and N-Methylation Reactions
The present analysis of the congocidine biosynthetic gene cluster
does not allow us to unambiguously determine the order in which
the different condensations and the methylation of the pyrrole
groups occur. This order could be different from the one pre-
sented in Figure 4: the condensation reaction with guanidinoace-
tate may occur before (Figure 4) or after the condensation
reaction with 3-aminopropionamidine; the methylation of the
pyrrole groups is not necessarily the last step of the biosynthesis.
HPLC analysis of CGCL031 (deletion mutant of cgc15) culture
supernatants indicates that abolition of congocidine production
is accompanied by the accumulation of a product also absorbing
at 297 nm (Figure 2). LC-MS and MS-MS analyses demonstrate
that this product is N,N-didemethylcongocidine (Figure S4). As
LC-MS-MS analysis of the S. ambofaciens SPM110 also shows
the presence of a small amount of N-demethylcongocidine in
addition to congocidine (data not shown), these findings strongly
suggest that N-methylation of the pyrrole groups is the last step in
congocidine biosynthesis.
Specific Features of the NRPS Involved in Congocidine
Biosynthesis
Several features of the NRPS involved in congocidine biosyn-
thesis are worth considering. First, the aspartate residue (D235,
GrsA-PheA numbering) conserved in most adenylation domains
and involved in binding the a-amino group of amino acids is
replaced by a serine in Cgc18_A. This may indicate that the
substrate of Cgc18_A has no a-amino group and is thus consis-
tent with 4-aminopyrrole-2-carboxylate being the substrate.
Second, guanidinoacetyl-CoA is the most likely substrate for
one of the two condensation domains, Cgc2 and Cgc16 (see
above). This activation of a condensation domain substrate under
the form of a CoA thioester rather than a PCP-Ppant-thioester is
unusual. Other examples occur in the biosynthesis of lipopepti-
des such as CDA (Hojati et al., 2002) or fengycin (Steller et al.,
1999). In these biosynthetic systems, the lipidic chain is activatedChemistry & Biology 16as an acyl-CoA thioester that serves as substrate for the first
NRPS condensation domain. The use of CoA-activated sub-
strates illustrates the flexibility of NRPS enzymes. It also opens
possibilities for molecular engineering, as the use of CoA rather
than PCP-Ppant eliminates some protein/protein interactions.
Third, both Cgc2 and Cgc16 lack the glycine residue in the C3
HHxxxDG motif generally conserved in condensation domains
(Cgc2 motif: SHLAADL; Cgc16 motif: HHLVSDA) (Schwarzer
et al., 2003). Cgc2 is also missing the first histidine of the motif.
No particular role has been proposed for this histidine, but substi-
tution of the glycine residue with a leucine in the EntF C domain
(enterobactin biosynthesis) reduced activity by at least 1000-
fold (Roche and Walsh, 2003). In VibH (vibriobactin biosynthesis),
however, the same mutation had no effect on catalytic efficiency
(Keating et al., 2002). The absence of congocidine production in
cgc2 and cgc16 deletion mutants (CGCL035 and CGCL032,
respectively) demonstrates that Cgc2 and Cgc16 are active
despite not having a glycine residue in the C3 motif.
The organization of congocidine NRPS domains is unusual:
half of these domains are free-standing domains (Cgc19, PCP
domain; Cgc2 and Cgc16, C domains), and the organization
of the only complete module, a free-standing module (Cgc18,
A-PCP-C), differs from the canonical C-A-PCP organization.
Free-standing A and PCP domains or A-PCP didomains are
frequently found when an amino acid is modified prior to its incor-
poration into a natural product, such as in the biosyntheses of van-
comycin, aminocoumarins, or prodigiosin (Fischbach and Walsh,
2006). Free-standing C domains, however, are less frequent: few
have been reported, and they include those involved in the biosyn-
thesis of vibriobactin (VibH; Keating et al., 2000b), viomycin (VioM;
Thomas et al., 2003), or of the enediyne C-1027 (SgcC5; Liu et al.,
2002). In these three biosyntheses, the condensation reactions
catalyzed by the free-standing C domains involve a PCP-tethered
biosynthetic intermediate and a nucleophilic substrate free in
solution, as proposed in congocidine biosynthesis for the conden-
sation of guanidinoacetate. Although unusual, the organization of
congocidine NRPS is particularly suited to the synthesis of oligo-
pyrrole molecules. Indeed, an iteration of the condensation reac-
tion catalyzed by Cgc18_C between the bipyrrole attached to
Cgc19 and a third pyrrole residue attached to Cgc18_PCP would
yield a tripyrrole attached to Cgc19. This mechanism is in fact
plausible for the biosynthesis of distamycin, a molecule closely
related to congocidine (Figure 1B) that comprises three 4-amino-
pyrrole-2-carbonyl groups. This raises the issue of how pyrrole
polymerization is controlled by the enzyme, as it has been
shown that C domains exhibit substrate specificity mainly at the
acceptor, or aminoacyl, site (i.e., pyrrole site), whereas more
relaxed specificity is observed at the donor, or peptidyl, site (i.e.,
bipyrrole site) (Lautru and Challis, 2004). One possibility is that in
the case of Cgc18_C, there is strict substrate specificity at the
donor site.
No gene encoding the phosphopantetheinyl transferase
required for the posttranslational modification of the NRPS
is present in the congocidine biosynthetic gene cluster. A phos-
phopantetheinyl transferase is encoded by alpN in the alp
cluster, located in the terminal inverted repeats of the S. ambo-
faciens chromosome (Pang et al., 2004), but it is not known
whether this enzyme is the one involved in the congocidine
NRPS modification., 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 425
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Congocidine Biosynthetic Gene ClusterTable 1. Components of the Congocidine Biosynthetic Gene Cluster and Their Proposed Function
ORF
Product
Size (aa)
Best Blast Hit
SAM
Number
cgc
Number
GenBank
Accession
Number Species
Identity/
similarity
(%) Putative Function
Proposed Role
in Congocidine
Biosynthesis
SAMR0922 321 CAB62672 Streptomyces
coelicolor A3(2)
93/94 Pirin-like protein Not involved
SAMR0921 cgc3* 532 ABO65957 Geobacillus
thermodenitrificans
NG80-2
33/49 Acyl-CoA synthetase Congocidine
assembly
SAMR0920 cgc2* 611 AAU04845 Streptomyces
netropsis
75/84 ABC transporter,
ATP-binding protein
Resistance
SAMR0919 cgc1* 619 AAU04844 Streptomyces
netropsis
74/83 ABC transporter,
transmembrane protein
Resistance
SAMR0918 cgc1 223 AAU04843 Streptomyces
netropsis
61/71 Two-component
response regulator
Regulation
SAMR0917 cgc2 470 ABF87402 Myxococcus
xanthus DK 1622
35/48 NRPS, C domain Congocidine
assembly
SAMR0916 cgc3 485 ABQ67968 Sphingomonas
wittichii RW1
45/63 Aldehyde
dehydrogenase
Precursor
biosynthesis
SAMR0915 cgc4 181 CAE16290 Photorhabdus
luminescens subsp.
laumondii TTO1
54/71 Nucleoside 2-
deoxyribosyltransferase
Precursor
biosynthesis
SAMR0914 cgc5 297 CAE16289 Photorhabdus
luminescens subsp.
laumondii TTO1
50/67 Dihydroorotate
dehydrogenase
Precursor
biosynthesis
SAMR0913 cgc6 276 CAE16288 Photorhabdus
luminescens subsp.
laumondii TTO1
55/72 Creatininase Precursor
biosynthesis
SAMR0912 cgc7 377 No significant
alignment
Hypothetical protein Precursor
biosynthesis
SAMR0911 cgc8 436 ABV96412 Salinispora
arenicola CNS-205
52/65 Nucleotide sugar
dehydrogenase
Precursor
biosynthesis
SAMR0910 cgc9 327 ABC45959 Salinibacter
ruber DSM 13855
44/58 Nucleoside diphosphate
sugar epimerase/
dehydrogenase
Precursor
biosynthesis
SAMR0909 cgc10 360 EDT60921 Cyanothece sp.
PCC 8801
35/51 Glycosyltransferase Precursor
biosynthesis
SAMR0908 cgc11 254 ABE52488 Methanococcoides
burtonii DSM 6242
43/65 Sugar
nucleotidyltransferase
Precursor
biosynthesis
SAMR0907 cgc12 381 CAN94946 Sorangium
cellulosum ‘‘So ce 56’’
47/61 Nucleotide-sugar
aminotransferase
Precursor
biosynthesis
SAMR0906 cgc13 641 AAM23368 Thermoanaerobacter
tengcongensis MB4
25/44 Glycoside hydrolase Precursor
biosynthesis
SAMR0905 cgc14 302 EAQ78058 Blastopirellula
marina DSM 3645
31/48 Amidohydrolase Precursor
biosynthesis
SAMR0904 cgc15 268 CAJ36215 Uncultured
methanogenic
archaeon RC-I
32/46 Methyltransferase Methylation
of pyrrole
groups
SAMR0903 cgc16 445 ZP_00110264 Nostoc
punctiforme PCC 73102
37/55 NRPS, C domain Congocidine
assembly
SAMR0902 cgc17 348 EAT61433 Geobacter sp. FRC-32 38/50 Alcohol dehydrogenase Precursor
biosynthesis
SAMR0901 cgc18 1067 CAO90637 Microcystis
aeruginosa PCC 7806
36/53 NRPS, A-PCP-C
domains
Congocidine
assembly
SAMR0900 cgc19 121 ABX06605 Herpetosiphon
aurantiacus
ATCC 23779
37/50 NRPS, PCP domain Congocidine
assembly426 Chemistry & Biology 16, 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved
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ORF
Product
Size (aa)
Best Blast Hit
SAM
Number
cgc
Number
GenBank
Accession
Number Species
Identity/
similarity
(%) Putative Function
Proposed Role
in Congocidine
Biosynthesis
SAMR0899 221 BAG18463 Streptomyces
griseus subsp.
griseus NBRC 13350
72/80 RNA polymerase ECF
subfamily s factor
Not involved
SAMR0898 217 BAG18464 Streptomyces
griseus subsp.
griseus NBRC 13350
64/74 Hypothetical protein Not involved
SAMR0897 100 CAB65634 Streptomyces
coelicolor A3(2)
71/79 Membrane protein Not involved
NRPS, nonribosomal peptide synthetase; C, condensation; A, adenylation; PCP, peptidyl carrier protein. Percentages of identity/similarity refer to
deduced amino acid sequence comparisons.Origin of Congocidine Precursors
As indicated above, 3-aminopropionamidine, guanidinoacetate,
and 4-aminopyrrole-2-carboxylate are the putative precursors of
congocidine. To our knowledge, there is no known biosynthetic
pathway for 3-aminopropionamidine, and the origin of this mole-
cule cannot easily be inferred from the analysis of the cgc gene
cluster.
The second probable precursor of congocidine is guanidinoa-
cetate. It is a known precursor in the biosynthesis of cylindrosper-
mopsin (Burgoyne et al., 2000), in which it is biosynthesized via
transamidination of glycine by an amidinotransferase, CyrA,
with arginine being the most likely donor of the guanidino groupChemistry & Biology 16,(Mihali et al., 2008). No amidinotransferase is encoded within
the cgc gene cluster, and there are no other obvious candidate
genes for the biosynthesis of guanidinoacetate among the
cgc genes. Nonetheless, incorporation experiments with isotopi-
cally labeled precursors have shown that the guanidinium moiety
of congocidine originates from arginine (Wildfeuer, 1964).
SAML1205, a protein predicted to belong to the amidinotransfer-
ase family (PF02274), is encoded elsewhere in the genome of
S. ambofaciens. Although genes directing the biosynthesis of
secondary metabolites are usually clustered in the chromosome,
this protein may catalyze the synthesis of guanidinoacetate.
Were this the case, however, all the heterologous hosts testedFigure 4. Proposed Pathway for Congocidine Assembly
A, adenylation domain; PCP, peptidyl carrier protein; C, condensation domain.421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 427
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S. fungicidicus B-5477, and S. albus) would have to have
a homolog of SAML1205 in their genomes. Such a homolog,
SCO1222, is present in the S. coelicolor M145 genome and, as
S. coelicolor and S. lividans are close relatives, it is likely that
a homolog of SCO1022/SAML1205 is also present in the S. livid-
ans genome.
The last identified precursor of congocidine is 4-aminopyrrole-
2-carboxylate. Recently, Walsh and colleagues reviewed all
known pathways for pyrrole biosynthesis, including pyrrole-2-
carboxylate (Walsh et al., 2006). This molecule is a constituent
of many secondary metabolites and is found in prodiginines, clor-
obiocin, and pyoluteorin, for example. In these metabolites,
pyrrole-2-carboxylate is synthesized from proline: a proline-
specific adenylation domain activates the amino acid and trans-
fers it to a PCP domain; a flavin-dependent dehydrogenase then
catalyzes the dehydrogenation of proline to yield pyrrolyl-2-
carboxyl-S-PCP. A similar mechanism is plausible for congoci-
dine biosynthesis, proline being activated by Cgc18_A and
dehydrogenated as a prolyl thioester on Cgc18-PCP and Cgc19.
However, no homolog of the flavin-dependent dehydrogenase is
encoded within the cgc gene cluster. Moreover, amino acids in
Cgc18_A predicted to confer substrate specificity differ from the
amino acids known to confer proline specificity. Thus, it appears
unlikely that 4-aminopyrrole-2-carboxylate is synthesized via
this mechanism. No homolog of the enzymes required for other
known biosyntheses of pyrrole molecules are encoded in the
cgc gene cluster, so the biosynthetic pathway for 4-aminopyr-
role-2-carboxylate in congocidine biosynthesis is probably novel.
Regulation and Resistance
Congocidine biosynthesis is probably controlled by cgc1, the
only gene in the cgc cluster predicted to be involved in regula-
tion. This gene codes for a putative transcriptional regulator.
The predicted Cgc1 protein contains a C-terminal DNA-binding
HTH domain and belongs to the two-component response regu-
lator family. It is similar (61% identity, 71% similarity) to the
product of the partial open reading frame (ORF10) identified
upstream from netP1 in S. flavopersicus NRRL 2820 (Stumpp
et al., 2005).
Two genes, cgc1* and cgc2*, code for transmembrane and
ATP-binding proteins, respectively, constituting ABC transport
systems. Cgc1* and Cgc2* are similar to NetP1 (74% identity,
83% similarity) and NetP2 (75% identity, 84% similarity), respec-
tively, proteins that have been shown to confer resistance to
netropsin (congocidine) in S. flavopersicus NRRL 2820 (Stumpp
et al., 2005). It is therefore likely that Cgc1* and Cgc2* confer resis-
tance to congocidine in Streptomyces. To test this, we inserted
a 5.4 kb fragment containing cgc1* and cgc2* into pSET152,
yielding pCGC502. This plasmid was introduced into S. lividans
TK23 by protoplast transformation to give the strain CGCL001.
CGCL001 grew on HT plates containing 20 mg/ml congocidine
whereas the control did not (Figure S5), demonstrating that
cgc1* andcgc2* aresufficient toconfer resistance tocongocidine.
Resistance mechanisms in antibiotic producer strains can
involve several genes, some of which may not be clustered with
the biosynthetic genes. To investigate whether genes located
outside the congocidine cluster participate in congocidine resis-
tance inS. ambofaciens, we used a strain (CGCA019) in which the428 Chemistry & Biology 16, 421–431, April 24, 2009 ª2009 Elseviechromosomal region encompassing cgc3* to cgc18 is deleted.
The resistance of this mutant strain to congocidine was assessed
as described above and compared to that of the parental
SPM110 strain containing the complete cgc cluster (Figure S5).
The CGCA019 strain is more sensitive than the SPM110 strain
to congocidine and its sensitivity is similar to that of S. lividans
TK23, suggesting that no other gene outside the cluster is
involved in congocidine resistance.
Genes of Unknown Function in Congocidine
Biosynthesis
Of the 22 genes constituting the congocidine biosynthetic gene
cluster, only nine can be assigned a function, either in resistance
to congocidine (cgc1* and cgc2*), biosynthesis regulation (cgc1),
or congocidine assembly (cgc3*, cgc2, cgc15, cgc16, cgc18,
and cgc19). The role of the 13 other genes, most of which
code for enzymes, in congocidine biosynthesis is unknown. It
is likely that some of these genes are involved in the biosynthesis
of the precursors of congocidine, as the origin of these precur-
sors has not yet been identified. Nonetheless, the presence of
six genes encoding enzymes similar to those involved in sugar
biosynthesis and transfer (cgc8 to cgc13) is puzzling, as congo-
cidine does not contain any sugar moiety. One hypothesis is that
a glycosylated form of congocidine is produced by S. ambofa-
ciens, and that this putative glycosylated form has not yet
been isolated. However, no such product has been detected
in culture supernatants or in cell extracts of S. ambofaciens
SPM110 (data not shown). The presence of a gene coding for
a putative glycosyltransferase (Cgc10) and another coding for
a putative glycoside hydrolase (Cgc13) might suggest the exis-
tence of a self-resistance mechanism involving inactivation of
congocidine by intracellular glycosylation and extracellular reac-
tivation by hydrolysis of the added sugar. This type of inactiva-
tion/reactivation mechanism by glycosylation/hydrolysis has
been demonstrated in Streptomyces antibioticus, the producer
of oleandomycin (Quiro´s et al., 1998). Nonetheless, the predicted
intracellular localization of Cgc13 and the absence of congoci-
dine production in CGCL017 (the cgc10 deletion mutant;
Figure 2D) do not support this model.
SIGNIFICANCE
We report here the isolation of the gene cluster directing the
biosynthesis of the pyrrole-amide antibiotic congocidine
from S. ambofaciens. A striking feature of this cluster is
the absence of obvious candidate genes for the biosynthesis
of the three putative congocidine precursors. This could
have been anticipated for 3-aminopropionamidine, for which
no biosynthetic pathway has yet been described. However, it
is surprising that biosynthesis of the other two precursors,
guanidinoacetate and 4-aminopyrrole-2-carboxylate, does
not seem to involve any known pathway.
Congocidine is assembled by a nonribosomal peptide
synthetase that displays some unusual features. Its single
adenylation domain acts iteratively, andone of its condensa-
tion domains uses CoA- rather than PCP-Ppant-activated
guanidinoacetate as a substrate. Moreover, it is constituted
of amodule and domains that are free standing. This organi-
zation and the proposed enzymemechanismmay also applyr Ltd All rights reserved
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cially of distamycin, which comprises three 4-aminopyrrole-
2-carbonyl groups; however, it also raises thequestion of the
control of pyrrole polymerization by the enzyme. These find-
ings illustrate the versatility of the NRPS family of enzymes.
Ourworkprovidesabasis for theelucidationof themolecular
principles of the biosynthesis of antibiotics of the pyrrole-
amide family and paves theway for the isolation and charac-
terization of biosynthetic gene clusters of known or new
pyrrole-amides. Once deciphered, the biosynthetic path-
ways of these molecules may well provide new tools for
biological engineering and combinatorial biosynthesis.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Culture Conditions
Strains and plasmids used are listed in Table S1. E. coli and B. subtilis strains
were grown in LB or SOB media supplemented with 30 mM MgSO4 and with
appropriate antibiotics as necessary. HT or SFM media (Kieser et al., 2000)
were used for genetic manipulations of Streptomyces strains and spore stock
preparations. For congocidine production, Streptomyces strains were grown
in MP5 medium (Pernodet et al., 1993).
Preparation and Manipulation of DNA
E. coli transformation and E. coli/Streptomyces conjugation were performed
according to standard procedures (Sambrook and Russell, 2001; Kieser
et al., 2000). The GC-rich PCR system (Roche) was used to amplify the att3aac
and FRTaac cassettes used. Taq polymerase from QIAGEN was used for PCR
for the verification of gene deletions in BACs or Streptomyces strains. DNA
fragments were purified from agarose gels using the GFX-PCR and gel band
purification kit from GE Healthcare. All oligonucleotides used in this study
are listed in Table S2.
Construction of the cgc18 Insertion Mutant
An internal fragment of cgc18 was amplified by PCR from S. ambofaciens
ATCC23877 genomic DNA using the primers Congo-D and Congo-R. The 815
bp product was purified and inserted into pGEM-T-Easy (Promega). The
EcoRI/Klenow fragment from the resulting plasmid was ligated into EcoRV-
digested pOSV202, yielding pJMC101. This plasmid was introduced into
S. ambofaciens SPM110 by conjugation with E. coli S17.1. Transconjugants
were selected on 50 mg/ml HT-apramycine, and integration of pJMC101 into
the chromosome of the resultingstrain, CGCA004,was verified by Southern blot.
Heterologous Expression of the cgcGene Cluster in S. lividans TK23
The BAC pCGC001 was engineered to allow conjugational transfer from E. coli
and integration into the Streptomyces chromosome. First, the aac(3)IV-oriT,
BamHI/Klenow/XbaI fragment from pPAOI6 was replaced with the hyg-oriT,
HindIII/Klenow/XbaI fragment from pOSV010 (Karray, 2005) to give
pOSV201. Then, the 5.3 kb PvuII fragment containing Uhyg, oriT, the FC31 in-
tegrase gene, and the attP site was purified and introduced into HpaI-digested
pCGC001, yielding pCGC002. This BAC was introduced into S. lividans TK23
by conjugation with E. coli S17.1. Transconjugants were selected on 50 mg/ml
HT-hygromycin, and the presence of Uhyg was verified by PCR using the
primers OMEGA A1 and OMEGA HYG2. The S. lividans TK23 strain containing
pCGC002 integrated into its chromosome was named CGCL006.
Construction of Strains CGCL009, CGCL010, CGCL026, CGCL027,
CGCL028, CGCL029, and CGCL035
PCR targeting (Yu et al., 2000) was used to delete the sequences between
SAMR898 and pBeloBAC11, between cgc3* and pBeloBAC11, as well as
the SAMR898 and SAMR899 genes, generating the strains CGCL009,
CGCL010, CGCL026, and CGCL027, respectively.
In pCGC002, the region between SAMR0898 and pBeloBAC11 was
replaced with the att3aac (Karray, 2005) cassette amplified with the primers
Seq_amontF and Seq_amontR. The resulting BAC, pCGC016, was introduced
into E. coli DH5a containing the plasmid pOSInt3 (Raynal et al., 1998) to exciseChemistry & Biology 16the att3aac cassette, yielding the BAC pCGC017. This BAC was verified by
BamHI digestion and introduced into S. lividans TK23 by conjugation with
E. coli S17.1 (pCGC017). Mutants were selected on 50 mg/ml hygromycin
and verified by PCR using the primers OMEGA A1 and OMEGA HYG2. The
resulting deletion strain was named CGCL009.
This protocol was repeated to delete the region between SAMR0921 and
pBeloBAC11 from pCGC017, yielding successively pCGC018 (containing
the att3aac cassette) and pCGC019 (cassette excised). The S. lividans TK23
strain containing pCGC018 obtained after conjugation was named CGCL010.
SAMR0898 and SAMR0899 were deleted from pCGC019 and cgc2, cgc19,
and cgc18 from pCGC002 by application of the same procedure. Replace-
ments of the genes by the att2aac cassette (for cgc2) and by the att3aac
cassette (for cgc19 and cgc18) yielded the BACs pCGC025, pCGC026,
pCGC049, pCGC035, and pCGC039, and excisions of the cassettes resulted
in the BACs pCGC029, pCGC030, pCGC057, pCGC038, and pCGC040,
respectively. Replacements and excisions were verified by PCR. The BACs
were integrated into the S. lividans chromosome as previously described
and the constructs verified by PCR. The resulting strains were named
CGCL026, CGCL027, CGCL035, CGCL028, and CGCL029.
Construction of Strains CGCL016, CGCL017, CGCL030, CGCL031,
and CGCL032
PCR-based REDIRECT technology was used to construct the cgc7, cgc10,
cgc3*, cgc15, and cgc16 deletion mutants (Gust et al., 2004). In pCGC002,
cgc7, cgc10, cgc3*, cgc15, and cgc16 were replaced, respectively, with the
FRTaac cassette from pW60, yielding the BACs pCGC208, pCGC212,
pCGC220, pCGC222, and pCGC224. The BACs pCGC208, pCGC212,
pCGC220, pCGC222, and pCGC224 were introduced into E. coli BT340 to
excise the disruption cassettes, resulting in pCGC209, pCGC213, pCGC221,
pCGC223, and pCGC225, respectively. Gene deletions were confirmed by
PCR. The mutagenized BACs pCGC209, pCGC213, pCGC221, pCGC223,
and pCGC225 were introduced intoS. lividansTK23 by RP4-based conjugation
from E. coli ET12567 containing pUZ8002 and selected for hygromycin. The
presence of the BACs in S. lividans TK23 was verified by PCR using the same
oligonucleotides as used to confirm gene deletions. The resulting cgc7,
cgc10, cgc3*, cgc15, and cgc16 deletion mutant strains were named
CGCL016, CGCL017, CGCL030, CGCL031, and CGCL032.
Construction of Strain CGCL001
The BAC pCGC001 was digested with TfiI. A 5.4 kb fragment containing cgc1*,
cgc2*, the 50 extremity of cgc3*, and the intergenic region between cgc1* and
cgc1, likely to contain the promoter region of cgc1*, was blunt ended by
Klenow enzyme and ligated into EcoRV-digested pSET152. The resulting
plasmid, pCGC502, was introduced into S. lividans TK23 by protoplast trans-
formation. Transformants were selected on 50 mg/ml apramycin. Resistance
to congocidine of the resulting strain, CGCL001, of S. lividans TK23, and of
S. lividans TK23 carrying the empty vector pSET152 was determined on HT
plates containing 20 mg/ml congocidine after 4 days of incubation at 30C.
Construction of CGCA019
Twenty-onecgcgenes, fromcgc3* tocgc18, were replaced with a hygromycin-
resistance cassette in the strain SPM110, already mutated in the spiramycin
biosynthetic cluster. To delete the cgc genes, two fragments, a 1.2 kb
fragment internal to cgc3* and a 1.5 kb fragment overlapping cgc18 and
cgc19, were generated by PCR using the primers CG3+F, CG3+R, CG18_SNF,
and CG18_SNR. An insert consisting of the att3Uhyg cassette flanked by these
two fragments was inserted into the suicide vector pOJ260 (Bierman et al.,
1992) to give pCGC516. This plasmid was introduced into S. ambofaciens
SPM110 by conjugation, and hygromycin-resistant apramycin-sensitive
clones were verified by PCR for the replacement of the cgc3*–cgc18 region
by the hygromycin-resistance cassette.
Congocidine Bioassay
The congocidine bioassay was carried out on HT plates. A patch of about 1 cm2
of the Streptomyces strain to be tested was grown at the center of the plate for
5 days at 30C. A 3 ml top layer of soft nutrient agar (Difco) containing the indi-
cator microorganisms E. coli or B. subtilis was then added onto the plates.
Growth inhibition zones were observed after overnight incubation at 37C., 421–431, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 429
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After 4 days of culture at 30C, supernatants were filtered through ultrafree-
MC (0.1 mm; Millipore) and analyzed on an Atlantis dC18 column (250 mm 3
4.6 mm, 5 mm, column temperature 30C) using an Agilent 1200 HPLC instru-
ment equipped with a quaternary pump. Samples were eluted with isocratic
0.1% HCOOH in H2O (solvent A):0.1% HCOOH in CH3CN (solvent B) (95:5)
at 1 ml/min for 7 min followed by a gradient to 40:60 A:B over 23 min. Congo-
cidine was detected by monitoring absorbance at 297 nm. A Bruker Daltonik
Esquire HCT ion trap mass spectrometer equipped with an orthogonal atmo-
spheric pressure interface-electrospray ionization (AP-ESI) source was used
for LC-MS analyses. Elution from the Atlantis dC18 was split into two flows:
1/10 was directed to an ESI-mass spectrometer for MS and MS-MS measure-
ments, and the remaining 9/10 to a diode array UV detector. In the ESI process,
nitrogen served as the drying and nebulizing gas, and helium gas was intro-
duced into the ion trap both for efficient trapping and cooling of the ions gener-
ated by the ESI and for fragmentation processes. Ionization was carried out in
positive/negative mode with a nebulizing gas set at 241 kPa, a drying gas set at
8 ml/min, and a drying temperature set at 340C for optimal spray and desol-
vation. Ionization and mass analysis conditions (capillary high voltage,
skimmer and capillary exit voltages, and ion transfer parameters) were tuned
for optimal detection of compounds in the range of masses between 100
and 600 m/z. For structural characterization by mass fragmentation, an isola-
tion width of 1 mass unit was used for isolating the parent ion. A fragmentation
energy ramp was used for automatically varying the fragmentation amplitude
to optimize the MS-MS fragmentation process.
SUPPLEMENTAL DATA
Supplemental data include five figures and two tables and can be found with
this article online at http://www.cell.com/chemistry-biology/supplemental/
S1074-5521(09)00113-6.
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